Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation

被引:51
|
作者
Amiral, J
Pouplard, C
Vissac, AM
Walenga, JM
Jeske, W
Gruel, Y
机构
[1] Hop Trousseau, Lab Hematol Hemostase, F-37044 Tours 1, France
[2] HYPHEN BioMed, F-78570 Andresy, France
[3] Loyola Univ, Med Ctr, Hemostasis Res Labs, Maywood, IL 60153 USA
关键词
heparin-induced thrombocytopenia; antibodies to heparin PF4; platelet activation;
D O I
10.1046/j.1365-2141.2000.02034.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antibodies to heparin platelet factor 4 (H-PF4) complexes were purified from the plasma of three patients with heparin-induced thrombocytopenia (HIT) using affinity chromatography. From each plasma, the largest amount of antibodies was eluted with 2 M NaCl at pH 7.5 (peak 1) and the remainder was obtained using 0.1 M glycine/0.5 M NaCl at pH 2.5 (peak 2). In an enzyme-linked immunosorbent assay (ELISA), we then showed that each patient had developed antibodies to PF4 displaying different characteristics. In patient 1, peak 1 IgG reacted almost exclusively with H-PF4 complexes, whereas peak 2 IgG had similar reactivity with PF4 whether or not heparin was present, Patient 2 expressed a mixture of IgA, IgM and IgG and both fractions bound to PF4 alone or to H-PF4 complexes. Finally. IgG in patient 3 only bound to H-PF4 and was unreactive with PF4 alone. Using [C-14]-serotonin release assays, the antibodies developed in the three patients and exhibiting the strongest ability to activate platelets with heparin were those having the highest affinity to H-PF4. These results strongly support the hypothesis that HIT antibodies to PF4 are heterogeneous regarding their affinity and specificity for target antigens and this may greatly influence their ability to activate platelets and their pathogenicity.
引用
收藏
页码:336 / 341
页数:6
相关论文
共 50 条
  • [41] Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia
    Nazy, I.
    Clare, R.
    Staibano, P.
    Warkentin, T. E.
    Larche, M.
    Moore, J. C.
    Smith, J. W.
    Whitlock, R. P.
    Kelton, J. G.
    Arnold, D. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (07) : 1402 - 1412
  • [42] CXCL4-platelet factor 4, heparin-induced thrombocytopenia and cancer
    Sandset, Per Morten
    [J]. THROMBOSIS RESEARCH, 2012, 129 : S97 - S100
  • [43] HEPARIN-INDUCED THROMBOCYTOPENIA - MECHANISM OF INTERACTION OF THE HEPARIN-DEPENDENT ANTIBODY WITH PLATELETS
    CHONG, BH
    FAWAZ, I
    CHESTERMAN, CN
    BERNDT, MC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (02) : 235 - 240
  • [44] Spontaneous heparin-induced thrombocytopenia syndrome without any proximate heparin exposure, infection, or inflammatory condition: Atypical clinical features with heparin-dependent platelet activating antibodies
    Okata, Takuya
    Miyata, Shigeki
    Miyashita, Fumio
    Maeda, Takuma
    Toyoda, Kazunori
    [J]. PLATELETS, 2015, 26 (06) : 602 - 607
  • [45] Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells
    Blank, M
    Shoenfeld, Y
    Tavor, S
    Praprotnik, S
    Boffa, MC
    Weksler, B
    Walenga, MJ
    Amiral, J
    Eldor, A
    [J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (02) : 121 - 129
  • [46] Heparin-induced thrombocytopenia: The role of platelet activation and therapeutic implications
    Haas, S
    Walenga, JM
    Jeske, WP
    Fareed, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 67 - 75
  • [47] DIFFERENT PLATELET SPECIFICITIES OF HEPARIN-DEPENDENT PLATELET AGGREGATING FACTORS IN HEPARIN-ASSOCIATED IMMUNE THROMBOCYTOPENIA
    PFUELLER, SL
    DAVID, R
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (01) : 149 - 159
  • [48] HEPARIN-INDUCED THROMBOCYTOPENIA - EFFECT OF HEPARIN PLATELET ANTIBODY ON PLATELETS
    CHONG, BH
    GRACE, CS
    ROZENBERG, MC
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1981, 49 (04) : 531 - 540
  • [49] THE ROLE OF PLATELET FACTOR-IV IN IN-VITRO PLATELET ACTIVATION-INDUCED BY THE ANTIBODIES FROM PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    GEROTZIAFAS, GT
    LECRUBIER, C
    MAKRIS, PE
    LECOMPTE, T
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1064 - 1064
  • [50] HEPARIN-INDUCED THROMBOCYTOPENIA - ASSOCIATION OF THROMBOTIC COMPLICATIONS WITH HEPARIN-DEPENDENT IGG ANTIBODY THAT INDUCES THROMBOXANE SYNTHESIS AND PLATELET-AGGREGATION
    CHONG, BH
    PITNEY, WR
    CASTALDI, PA
    [J]. LANCET, 1982, 2 (8310): : 1246 - 1249